Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 29Stomach Neoplasms 25Rectal Neoplasms 25Colonic Neoplasms 13Neoplasm Metastasis 3Adenocarcinoma 3Neoplasms 2Gastrointestinal Neoplasms 2Recurrence 1Peripheral Nervous System Diseases 1Metastatic HER2 Positive Gastroesophageal Junction Cancer 1Locally Advanced Rectal Cancer (LARC) 1Locally Advanced Rectal Cancer 1Locally Advanced Gastric Cancer 1Locally Advanced Colorectal Cancer 1Intestinal Neoplasms 1HER2-positive Locally Advanced Resectable Gastric Cancer 1HER2-positive Colorectal Cancer 1Gastrointestinal Diseases 1Gastric Cancer Stage 1Gastric Adenocarcinoma 1Esophageal Neoplasms 1Digestive System Diseases 1Colorectal Cancer Metastatic 1Colonic Diseases 1Carcinoma 1

Interventions

XELOX 1Omeprazole 1N,N'-bis(pyridoxal-5-phosphate)ethylenediamine-N,N'-diacetic acid 1Massage 1Low-Level Light Therapy 1Gloves, Surgical 1Folfox protocol 1Fish Oils 1Exercise 1Corn Oil 1Amplified Fragment Length Polymorphism Analysis 1Acetylcysteine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Peripheral Nervous System Diseases × XELOX × Gastrointestinal × Clear all
NCT02590367 2015-12-02

Estimate the Efficacy of HD6610 Granule for Oxaliplatin-induced Peripheral Neuropathy

Jiangsu Province Hospital of Traditional Chinese Medicine

Phase 2/3 Unknown
64 enrolled
Gastrointestinal

Peripheral Nervous System Diseases, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡